Journals / Turkish Journal of Immunology / 2017 / Cilt: 5 - Sayı: 2

Effect of Pro-inflammatory Markers on Gestational Diabetes

Gebelik Diyabetinde Pro-enflamatuvar Belirteçlerin Etkisi

Pages
45–50
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

A positive correlation between MPO and triglyceride and negative correlation between MPO and HDLwas observed (p=0.017; p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Gestational diabetes, which is a subtype of hyperglycemia; can cause fetal mortality and also maycause diabetes mellitus after pregnancy.
📊
Key Findings & Data:In this study, weaimed to evaluate in a broad perspective the pro-inflammatory cytokines which may be linked to gestational diabetesin relation to biochemical parameters.Method: This study was performed with 49 patients who had gestational diabetes mellitus (GDM) diagnosis and 28healthy pregnant women.
💡
Conclusion & Impact:A positive correlation between MPO and triglyceride and negative correlation between MPO and HDLwas observed (p=0.017; p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Introduction: Gestational diabetes, which is a subtype of hyperglycemia; can cause fetal mortality and also maycause diabetes mellitus after pregnancy. Even though there are studies indicating that inflammation may cause thedevelopment of diabetes during gestation, roles of osteoprotegerin and resistin remain unknown. In this study, weaimed to evaluate in a broad perspective the pro-inflammatory cytokines which may be linked to gestational diabetesin relation to biochemical parameters.Method: This study was performed with 49 patients who had gestational diabetes mellitus (GDM) diagnosis and 28healthy pregnant women. Serum levels of leptin, resistin, CD40L, TNF-R (Tumor Necrotizing Factor Receptor), OPG(Osteoprotegerin), MCP-1 (Monocyte Chemoattractant Protein), MPO (Myeloperoxidase), ICAM-1 (IntercellularAdhesion Molecule) were analysed and compared to blood glucose levels, HbA1c, total cholesterol, triglycerid, LDLand HDL cholesterol levels.Results: Serum OPG (p=0.043) and sTNF-R (p=0.001) levels were found significantly higher in GDM patientscompared to healthy controls, whereas resistin levels were found lower. Even though a statistically meaningful differencewas not observed, inflammatory markers MPO, ICAM-1, CD40L, and leptin were also found higher compared tocontrol group. A positive correlation between MPO and triglyceride and negative correlation between MPO and HDLwas observed (p=0.017; p

Özet

Giriş: Hipergliseminin bir alt tipi olan Gebelik Diyabeti fetal ölüme ve gebelik sonrasında diyabet mellitusa neden olabilmektedir. İnflamasyonun gebelik sırasında diyabete yol açtığını bildiren araştırmalar olmasına rağmen, osteoprotegerin ve resistinin rolü henüz bilinmemektedir. Bu araştırmada, gebelik diyabeti ile i-lişkili olabilecek proenflamatuvar sitokinleri geniş bir perspektifle inceleyerek biyokimyasal parametrelerle birlikte değerlendirdik. Yöntem: Bu çalışma Gebelik Diyabeti tanısı almış 49 gebe ve 28 sağlıklı gebe kadın ile gerçekleştirilmiştir. Leptin, resistin, CD40L, TNF-R (Tümör Nekrotizan Faktör Reseptörü), OPG (Osteoprotegerin), MCP-1 (Monosit Kemoatraktan Protein-1), MPO (Miyeloperoksidaz), ICAM-1 (Hücreler arası adhezyon Molekülü) düzeyleri ölçülüp kan glukoz, HbA1c, total kolesterol, trigliserid, LDL ve HDL kolesterol düzeyleri ile birlikte değerlendirilmiştir. Sonuçlar: Resistin düzeyleri düşük düzeyde saptanırken, serum OPG (p=0,043) ve sTNF-R (p=0,001) düzeyleri sağlıklı kontrollere göre gebelik diyabeti olanlarda belirgin olarak artmış düzeydedir. Bu hasta grubunda, istatistiksel olarak anlamlı olmasa da, MPO, ICAM-1, CD40L ve leptin düzeyleri sağlıklı gebelerden daha yüksek düzeyde saptanmıştır. MPO ve trigliserid düzeyleri arasında pozitif yönde bir korelasyon varken, MPO ve HDL düzeyleri arasında negatif korelasyon olduğu saptanmıştır (p=0,017; p0,05). Tartışma: Pro-enflamatuvar belirteçlerin diyabette rolü henüz açıklığa kavuşmamış durumdadır. Gebelik diyabeti olanlarda inflamasyon belirteçlerinin yüksek oranda olması Gebelik Diyabeti patogenezinin anlaşılmasında yararlı olabilir. Daha büyük hasta grupları ile yapılacak çok merkezli araştırmalar pro-enflamatuvar belirteçlerin gebelik diyabetine etkisini açıklığa kavuşturucu olacaktır.

🔖

Cite This Article

AYDIN, H., ŞİT, D., İSPİR, T., DALAN, A. B., AKDENİZ, F. T., AKBULUT, Z., DEMİREL, G. Y., SARI, H. (2022). Effect of Pro-inflammatory Markers on Gestational Diabetes. Turkish Journal of Immunology, Cilt: 5 - Sayı: 2, 45–50. https://ajindex.com/articles/607234

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Carr DB, Gabbe S. Gestational Diabetes: Detection, Management and Implications. Clinical Diabetes 1998;16:4–11.
  2. Al-Noaemi MC, Shalayel MHF. Pathophysiology of Gestational Diabetes Mellitus: The Past, The Present and The Future, Gestational Diabetes. Radenkovica M, editor; 2011. Available from: https://www.intechopen.com/books/gestational-diabetes/ pathophysiology-of-gestational-diabetes-mellitus-the-past-thepresent-and-the-future doi: 10.5772/24315 Desoye G, Hauguel-de Mouzon S. The human placenta in gestational diabetes mellitus. The insulin and cytokine network. Diabetes Care 2007;30 Suppl 2:S120–6. doi: 10.2337/dc07-s203 Kuzmicki M, Telejko B, Szamatowicz J, Zonenberg A, Nikolajuk A, Kretowski A, Gorska M. High resistin and interleukin-6 levels are associated with gestational diabetes mellitus. Gynecol Endocrinol 2009;25:258–63. doi: 10.1080/09513590802653825 World Medical Association. Helsinki Declaration. https://www. wma.net/publications/ Ceriello A, Falleti E, Motz E, Taboga C, Tonutti L, Ezsol Z, Gonano F, Bartoli E. Hyperglycemia-induced circulating ICAM1 increase in diabetes mellitus: the possible role of oxidative stress. Horm Metab Res 1998;30:146–9. doi: 10.1055/s-2007-978854
  3. Huang SW, Seow KM, Ho LT, Chien Y, Chung DY, Chang CL, Lai YH, Hwang JL, Juan CC. Resistin mRNA levels are downregulated by estrogen in vivo and in vitro. FEBS Lett 2005;579:449–54. doi: 10.1016/j.febslet.2004.12.010 Ryser MD, Qu Y, Komarova SV. Osteoprotegerin in bone metastases: mathematical solution to the puzzle. PLoS Comput Biol 2012;8:e1002703. doi: 10.1371/journal.pcbi.1002703 Bord S, Ireland DC, Beavan SR, Compston JE. The effects of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts. Bone 2003;32:136–41.
  4. Akinci B, Celtik A, Yuksel F, Genc S, Yener S, Secil M, Ozcan MA, Yesil S. Increased osteoprotegerin levels in women with previous gestational diabetes developing metabolic syndrome. Diabetes Res Clin Pract 2011;91:26–31. doi: 10.1016/j.diabres.2010.09.028 Codner E. Estrogen and type 1 diabetes mellitus. Pediatr Endocrinol Rev 2008;6:228–34.
  5. Secchiero P, Corallini F, Pandolfi A, Consoli A, Candido R, Fabris B, Celeghini C, Capitani S, Zauli G. An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction. J Pathol 2006;169:2236–44. doi: 10.2353/ajpath.2006.060398 Gomes CP, Torloni MR, Gueuvoghlanian-Silva BY, Alexandre SM, Mattar R, Daher S. C